Immediate Impact

9 from Science/Nature 63 standout
Sub-graph 1 of 22

Citing Papers

Strategies for targeting cytokines in inflammatory bowel disease
2024 Standout
Ulcerative colitis
2023 Standout
5 intermediate papers

Works of Mark Shapiro being referenced

Randomized, Double Blind Controlled Trial of Subcutaneous Recombinant Human Interleukin-11 Versus Prednisolone in Active Crohn's Disease
2005
Randomized, controlled trial of recombinant human interleukin‐11 in patients with active Crohn's disease
2002
and 1 more

Author Peers

Author Last Decade Papers Cites
Mark Shapiro 110 80 24 202 169 23 665
H. H. F. Derkx 45 112 51 214 301 24 757
Almuthe Hauer 90 224 23 109 252 27 579
Céline Ricour 57 52 18 75 64 19 824
Marla Shapiro 42 37 29 244 97 25 749
J. Y. Mary 30 180 35 314 219 16 801
Hervé Lefèvre 31 149 26 201 247 30 807
E D Srivastava 33 280 54 296 280 22 814
B. Huitfeldt 86 127 23 198 194 16 592
Ian Leibowitz 32 180 21 364 320 20 774
PJ Hamlin 28 136 7 413 339 21 810

All Works

Loading papers...

Rankless by CCL
2026